Skip to main content
. 2019 Mar 28;11(4):435. doi: 10.3390/cancers11040435
AML Acute myeloid leukemia
CCRCC Clear cell renal cell carcinoma
CENP-C Centromeric protein C
CIMP CpG island methylator phenotype
CRC Colorectal cancer
DFS Disease-free survival
EC Endometrial carcinoma
EEC Endometrioid endometrial carcinoma
EGFR Epidermal growth factor receptor
FAK Focal adhesion kinase
FISH Fluorescence in situ hybridation
GISTIC Genomic identification of significant targets in cancer
GBM Glioblastoma
IHC Immunohistochemistry
IL Interleukin
KIRC Kidney renal papillary carcinoma
KRAS Kirsten rat sarcoma
LGG Lower grade gliomas
MAN2C1 α-mannosidase 2C1
MAPK Mitogen-activated protein kinase
mCRC Metastatic colorectal cancer
MEK Mitogen-activated protein kinase kinase
miRNA Micro RNA
MMP Matrix metalloproteinase
MSI Microsatellite instability
mTOR Mammalian target of rapamycin
OS Overall survival
PBD PIP2-binding domain
PD-1 Programmed death-1
PD-L1 Programmed death ligand-1
PDAC Pancreatic ductal adenocarcinoma
PI3K PhosphatidylInositol 3-kinase
PTEN Phosphatase and tensin homolog deleted on chromosome 10
PICT-1 Protein interacting with carboxyl terminus 1
PIP2 PhosphatIdylinositol-4,5-bisphosphate
PIP3 Phosphatidylinositol-3,4,5-trisphosphate
RCC Renal cell carcinoma
TCGA The cancer genome atlas
TMA Tissue microarray
TME Tumor microenvironment
TNM Tumor, node, metastasis
UCEC Uterine corpus endometrial carcinoma